HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

V M Lipkin Selected Research

threonyl- glycyl- glutamyl- asparaginyl- histidylarginine

7/2017Studying the Specific Activity of the Amide Form of HLDF-6 Peptide using the Transgenic Model of Alzheimer's Disease.
9/2009Postischemic administration of HLDF-6 peptide ameliorates cognitive dysfunction and brain damage induced by chronic cerebral ischemia in rats.
1/2007Granulocyte differentiation inducer, hexapeptide HLDF-6, decreases cytotoxic effect of tumor necrosis factor on HL-60 cell line.
7/2006[Neuroprotective effect of the hexapeptide HLDF-6 on neurons of rat hippocampus on the model of Alzheimer's disease in vivo and in vitro].
3/2006Hexapeptides HLDF-6 and PEDF-6 restore memory in rats after chronic intracerebroventricular treatment with beta-amyloid peptide Abeta(25-35).
4/2005HLDF-6 peptide affects behavioral reactions and organism functions dependent on androgen hormones in normal and castrated male mice.
8/2004Different mechanisms of protective and differentiative activities of homological peptides TGENHR and TQVEHR.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


V M Lipkin Research Topics

Disease

12Leukemia
07/2020 - 05/2000
6Neoplasms (Cancer)
11/2020 - 05/2000
3Breast Diseases (Breast Disease)
11/2020 - 02/2020
3Alzheimer Disease (Alzheimer's Disease)
07/2017 - 03/2006
2Breast Neoplasms (Breast Cancer)
11/2020 - 07/2020
2Adenocarcinoma
07/2016 - 01/2014
1Neoplasm Metastasis (Metastasis)
11/2020
1Carcinoma (Carcinomatosis)
11/2020
1Lymphatic Metastasis
07/2020
1Stroke (Strokes)
07/2017
1Ischemia
07/2017
1Myopia
11/2012
1Degenerative Myopia
11/2012
1Cognitive Dysfunction
09/2009
1Brain Ischemia (Cerebral Ischemia)
09/2009
1Substance-Related Disorders (Drug Abuse)
04/2005
1Pain (Aches)
04/2005
1Hypoxia (Hypoxemia)
08/2004
1Pheochromocytoma
08/2002
1Adenoma (Adenomas)
08/2002
1Hyperplasia
10/2001
1Pituitary ACTH Hypersecretion
10/2001
1Hyperaldosteronism (Conn Syndrome)
10/2001
1Colonic Neoplasms (Colon Cancer)
04/2001
1Bone Neoplasms (Bone Cancer)
01/2001
1Wounds and Injuries (Trauma)
01/2001
1Osteosarcoma (Osteogenic Sarcoma)
05/2000
1Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2000

Drug/Important Bio-Agent (IBA)

7threonyl- glycyl- glutamyl- asparaginyl- histidylarginineIBA
07/2017 - 08/2004
6CytokinesIBA
11/2020 - 01/2002
5Peptides (Polypeptides)IBA
07/2017 - 08/2004
5fas Receptor (CD95 Antigen)IBA
08/2002 - 05/2000
3Proteins (Proteins, Gene)FDA Link
02/2020 - 05/2000
2Amyloid beta-PeptidesIBA
07/2017 - 03/2006
2pigment epithelium-derived factorIBA
11/2012 - 08/2004
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2007 - 11/2005
2RNA (Ribonucleic Acid)IBA
01/2002 - 05/2000
2DNA (Deoxyribonucleic Acid)IBA
01/2002 - 05/2000
2EnzymesIBA
10/2001 - 01/2001
1Progesterone Receptors (Progesterone Receptor)IBA
11/2020
1Estrogens (Estrogen)FDA Link
11/2020
1Interleukin-4 (Interleukin 4)IBA
11/2020
1Carcinoembryonic AntigenIBA
07/2020
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
07/2020
1Nootropic Agents (Nootropics)IBA
07/2017
1Ibotenic AcidIBA
07/2017
1AmidesIBA
07/2017
1CollagenIBA
11/2012
1Amyloid (Amyloid Fibrils)IBA
11/2012
1AntibodiesIBA
11/2012
1Dihydrotestosterone (Androstanolone)IBA
07/2006
1Neuroprotective AgentsIBA
07/2006
1Glutamic Acid (Glutamate)FDA Link
11/2005
1NF-kappa B (NF-kB)IBA
11/2005
1Sodium AzideIBA
08/2004
1AldosteroneIBA
08/2002
1Interleukin-10 (Interleukin 10)IBA
01/2002
1Nerve Growth Factors (Neurotrophins)IBA
08/2000
1Tretinoin (Retinoic Acid)FDA LinkGeneric
07/2000
1Peptide FragmentsIBA
07/2000
1LeptinIBA
05/2000
1Rhodopsin (Visual Purple)IBA
01/2000
1Retinal Pigments (Pigments, Visual)IBA
01/2000

Therapy/Procedure

1Therapeutics
11/2020